ATE437869T1 - Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere - Google Patents

Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere

Info

Publication number
ATE437869T1
ATE437869T1 AT04729974T AT04729974T ATE437869T1 AT E437869 T1 ATE437869 T1 AT E437869T1 AT 04729974 T AT04729974 T AT 04729974T AT 04729974 T AT04729974 T AT 04729974T AT E437869 T1 ATE437869 T1 AT E437869T1
Authority
AT
Austria
Prior art keywords
enantiomer
pyridinylmethyl
production
enriched form
individual enantiomers
Prior art date
Application number
AT04729974T
Other languages
English (en)
Inventor
Reddy B Parthasaradhi
Reddy K Rathnakar
Reddy Rapolu Raji
Reddy D Muralidhara
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35241611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE437869(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Application granted granted Critical
Publication of ATE437869T1 publication Critical patent/ATE437869T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04729974T 2004-04-28 2004-04-28 Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere ATE437869T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2004/000118 WO2005105786A1 (en) 2004-04-28 2004-04-28 A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers

Publications (1)

Publication Number Publication Date
ATE437869T1 true ATE437869T1 (de) 2009-08-15

Family

ID=35241611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04729974T ATE437869T1 (de) 2004-04-28 2004-04-28 Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere

Country Status (8)

Country Link
US (3) US7176319B2 (de)
EP (1) EP1740571B1 (de)
AT (1) ATE437869T1 (de)
DE (1) DE602004022337D1 (de)
DK (1) DK1740571T3 (de)
ES (1) ES2327926T3 (de)
PT (1) PT1740571E (de)
WO (1) WO2005105786A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2510849A1 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
MXPA05013316A (es) * 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
DK1748998T3 (da) * 2004-05-28 2010-05-10 Hetero Drugs Ltd Ny stereoselektiv syntese af benzimidazolsulfoxider
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
NZ579136A (en) 2007-02-21 2012-05-25 Cipla Ltd Process for the preparation of esomeprazole magnesium dihydrate
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
ATE533758T1 (de) 2007-09-25 2011-12-15 Hetero Drugs Ltd Verfahren zur herstellung von enantiomerenreinem esomeprazol
EP2195309A4 (de) * 2007-10-08 2013-04-24 Hetero Drugs Ltd Polymorphe von esomeprazolsalzen
EP2143722A1 (de) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Verfahren zur Herstellung von Esomeprazol-Natrium von hoher chemischer Reinheit und neue Formen von Esomeprazol-Natrium
US20100113527A1 (en) * 2008-09-30 2010-05-06 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole
US8354541B2 (en) 2008-11-18 2013-01-15 Hetero Research Foundation Optical purification of esomeprazole
WO2011058569A1 (en) 2009-11-12 2011-05-19 Hetero Research Foundation Process for the resolution of omeprazole
CN104011180B (zh) 2011-09-27 2017-09-05 沙特阿拉伯石油公司 氧化脱硫反应产物的选择性液‑液萃取

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US5984789A (en) * 1983-11-15 1999-11-16 Luk Lamellen Und Kupplungsbau Gmbh Assembly for taking up and compensating for torque induced shocks
SE8505112D0 (sv) 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
US7036725B2 (en) * 1995-06-06 2006-05-02 Smart Media Of Delaware, Inc. Shopping cart handle with built-in console for the input and display of consumer product information
US6422462B1 (en) * 1998-03-30 2002-07-23 Morris E. Cohen Apparatus and methods for improved credit cards and credit card transactions
CN100396675C (zh) * 1998-08-10 2008-06-25 加利福尼亚州大学董事会 质子泵抑制剂的前药
US6145741A (en) * 1999-04-27 2000-11-14 Wisdom; Juanita J. Universal pre-paid gasoline and travel card
WO2001031555A1 (en) * 1999-10-28 2001-05-03 Gould David B Prepaid cash equivalent card and system
US7099568B2 (en) * 2000-03-21 2006-08-29 Sony Corporation Information playback apparatus and electronic pop advertising apparatus
AU2002248227C1 (en) * 2000-12-19 2012-07-19 Paltronics, Inc. Video table game apparatus, system, and method of use
US7103573B2 (en) * 2001-04-02 2006-09-05 Privilegeone Networks, Llc User rewards program and associated communications system
US20020153424A1 (en) * 2001-04-19 2002-10-24 Chuan Li Method and apparatus of secure credit card transaction
US20020178063A1 (en) * 2001-05-25 2002-11-28 Kelly Gravelle Community concept for payment using RF ID transponders
US20040248941A1 (en) 2001-09-25 2004-12-09 Keiji Kamiyama Benzimidazone compound, process for producing the same, and use thereof
US20030066073A1 (en) * 2001-09-28 2003-04-03 Rebh Richard G. Methods and systems of interactive advertising
US20040044574A1 (en) * 2002-06-04 2004-03-04 Kordex, Inc. Apparatus for displaying local advertising to a display screen
AU2003242388A1 (en) 2002-06-14 2003-12-31 Takeda Pharmaceutical Company Limited Prodrug and process for producing the same
EP1515963B1 (de) 2002-06-27 2007-02-14 Dr. Reddy's Laboratories Ltd. Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze
ES2263028T3 (es) 2002-07-19 2006-12-01 Winston Pharmaceuticals Llc Derivados de bencimidazol y su uso como profarmacos de inhibidores de bomba de proton.
AU2003248880A1 (en) * 2002-11-26 2004-06-18 The Advertizing Firm, Inc. Method and system of advertising
US7593867B2 (en) * 2004-01-12 2009-09-22 The Coca-Cola Company Interactive networked product container
US7510123B2 (en) * 2004-11-18 2009-03-31 Goliath Solutions, Llc RF contact signal detector
US7055740B1 (en) * 2004-12-06 2006-06-06 Target Brands, Inc. Stored-value card adapted to be read by an electronic device
US7290714B2 (en) * 2005-01-18 2007-11-06 Target Brands, Inc. Stored-value card with light

Also Published As

Publication number Publication date
DK1740571T3 (da) 2009-11-02
US20070129405A1 (en) 2007-06-07
PT1740571E (pt) 2009-09-02
US20060089386A1 (en) 2006-04-27
US20070129406A1 (en) 2007-06-07
WO2005105786A1 (en) 2005-11-10
DE602004022337D1 (de) 2009-09-10
US7435826B2 (en) 2008-10-14
US7176319B2 (en) 2007-02-13
US7928240B2 (en) 2011-04-19
EP1740571A1 (de) 2007-01-10
EP1740571B1 (de) 2009-07-29
ES2327926T3 (es) 2009-11-05

Similar Documents

Publication Publication Date Title
ATE437869T1 (de) Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
DE602005011609D1 (de) Verbessertes verfahren zur herstellung von 3-hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen
DE602004030239D1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
EA200800908A1 (ru) Получение прегабалина и родственных соединений
DE602005024694D1 (de) Verfahren zur herstellung von mutierten polynukleotiden
ATE473955T1 (de) Verfahren zur herstellung von angereichertem isopulegol
DE602004025386D1 (de) Neue stereoselektive synthese von benzimidazolsulfoxiden
ATE466015T1 (de) Verfahren zur herstellung von phenserin und dessen analogon
ATE346061T1 (de) Verfahren zur herstellung von (s)-3-methylamino-1-(thien-2-yl)propan-1-ol
BG110206A (en) METHOD FOR MANUFACTURE OF ESCITALOPRAM
MY148301A (en) Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
DE50302888D1 (de) Verfahren zur herstellung reiner thioctsäure
ATE459723T1 (de) Verfahren zur herstellung von (4s)-3,4-dihydroxy- 2,6,6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase
EA200601513A1 (ru) Способ получения энантиомерно чистых 1-замещённых 3-аминоспиртов
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
ATE334980T1 (de) Verfahren zur herstellung von 2-methyl piperazine derivaten.
DE602004006021D1 (de) Verfahren zur racematspaltung von nefopam
ATE457356T1 (de) Verfahren zur herstellung von vorwiegend ein enantiomer enthaltendes 1,1,1-trifluorisopropanol
GB0417063D0 (en) Process for the preparation of optically-active compounds
DE50301526D1 (de) Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo(4.3.0)nonan unter Verwendung von Gegenstromchromatographie
DE50311960D1 (de) Verfahren zur Racematsspaltung von 3-Aminopentannitril
ATE353887T1 (de) Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze
EA200802400A1 (ru) Полиморфные формы и способ
ATE399876T1 (de) Chemoenzymatisches verfahren zur stereoselektiven herstellung von optisch-angereicherten phenylglycidate
DE602005026854D1 (de) Verfahren zur herstellung von hohen niveaus von interferon-beta

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1740571

Country of ref document: EP